However, scRNA-seq data revealed that only approximately 2% (927 out of total 45,627 cells) of tumor-infiltrating cells expressed CD103, and its expression level was generally low across all immune clusters (Supplemental Figure 14E). The gene discussed is ITGAE; the disease is neoplasm.